BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Berasain C, Ujue Latasa M, Urtasun R, Goñi S, Elizalde M, Garcia-Irigoyen O, Azcona M, Prieto J, Avila MA. Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer. Cancers (Basel) 2011;3:2444-61. [PMID: 24212818 DOI: 10.3390/cancers3022444] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Shehata F, Abdel Monem N, Sakr M, Kasem S, Balbaa M. Epidermal growth factor, its receptor and transforming growth factor-β1 in the diagnosis of HCV-induced hepatocellular carcinoma. Med Oncol 2013;30:673. [PMID: 23912699 DOI: 10.1007/s12032-013-0673-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
2 Mir IH, Guha S, Behera J, Thirunavukkarasu C. Targeting molecular signal transduction pathways in hepatocellular carcinoma and its implications for cancer therapy. Cell Biol Int 2021. [PMID: 34270844 DOI: 10.1002/cbin.11670] [Reference Citation Analysis]
3 Nikolova D, Chalovska V, Ivanova MG, Nikolovska E, Volkanovska A, Orovchanec N, Kunovska SK, Petrushevska G, Janevska V. Immunohistochemical Expression of Epidermal Growth Factor Receptor in Hepatocellular Carcinoma. Pril (Makedon Akad Nauk Umet Odd Med Nauki) 2018;39:21-8. [PMID: 30864368 DOI: 10.2478/prilozi-2018-0038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Raju GSR, Pavitra E, Merchant N, Lee H, Prasad GLV, Nagaraju GP, Huh YS, Han Y. Targeting autophagy in gastrointestinal malignancy by using nanomaterials as drug delivery systems. Cancer Letters 2018;419:222-32. [DOI: 10.1016/j.canlet.2018.01.044] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
5 Zhang K, Zhang M, Luo Z, Wen Z, Yan X. The dichotomous role of TGF-β in controlling liver cancer cell survival and proliferation. J Genet Genomics 2020;47:497-512. [PMID: 33339765 DOI: 10.1016/j.jgg.2020.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Barcena-Varela M, Lujambio A. The Endless Sources of Hepatocellular Carcinoma Heterogeneity. Cancers (Basel) 2021;13:2621. [PMID: 34073538 DOI: 10.3390/cancers13112621] [Reference Citation Analysis]
7 Bruban J, Voloudakis G, Huang Q, Kajiwara Y, Al Rahim M, Yoon Y, Shioi J, Gama Sosa MA, Shao Z, Georgakopoulos A, Robakis NK. Presenilin 1 is necessary for neuronal, but not glial, EGFR expression and neuroprotection via γ-secretase-independent transcriptional mechanisms. FASEB J 2015;29:3702-12. [PMID: 25985800 DOI: 10.1096/fj.15-270645] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
8 Carrasco-Torres G, Monroy-Ramírez HC, Martínez-Guerra AA, Baltiérrez-Hoyos R, Romero-Tlalolini MLÁ, Villa-Treviño S, Sánchez-Chino X, Vásquez-Garzón VR. Quercetin Reverses Rat Liver Preneoplastic Lesions Induced by Chemical Carcinogenesis. Oxid Med Cell Longev 2017;2017:4674918. [PMID: 28740570 DOI: 10.1155/2017/4674918] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
9 Nie X, Liu Y, Chen WD, Wang YD. Interplay of miRNAs and Canonical Wnt Signaling Pathway in Hepatocellular Carcinoma. Front Pharmacol 2018;9:657. [PMID: 29977206 DOI: 10.3389/fphar.2018.00657] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
10 Smekalova EM, Kotelevtsev YV, Leboeuf D, Shcherbinina EY, Fefilova AS, Zatsepin TS, Koteliansky V. lncRNA in the liver: Prospects for fundamental research and therapy by RNA interference. Biochimie 2016;131:159-72. [DOI: 10.1016/j.biochi.2016.06.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
11 Yuan CH, Sun XM, Zhu CL, Liu SP, Wu L, Chen H, Feng MH, Wu K, Wang FB. Amphiregulin activates regulatory T lymphocytes and suppresses CD8+ T cell-mediated anti-tumor response in hepatocellular carcinoma cells. Oncotarget 2015;6:32138-53. [PMID: 26451607 DOI: 10.18632/oncotarget.5171] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
12 Chen J, Zeng F, Forrester SJ, Eguchi S, Zhang M, Harris RC. Expression and Function of the Epidermal Growth Factor Receptor in Physiology and Disease. Physiological Reviews 2016;96:1025-69. [DOI: 10.1152/physrev.00030.2015] [Cited by in Crossref: 61] [Cited by in F6Publishing: 33] [Article Influence: 10.2] [Reference Citation Analysis]
13 Zheng P, Huang Z, Tong DC, Zhou Q, Tian S, Chen BW, Ning DM, Guo YM, Zhu WH, Long Y, Xiao W, Deng Z, Lei YC, Tian XF. Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways. World J Gastrointest Oncol 2022; 14(2): 450-477 [DOI: 10.4251/wjgo.v14.i2.450] [Reference Citation Analysis]
14 Wang J, Zhou Y, Guo S, Wang Y, Nie C, Wang H, Wang J, Zhao Y, Li X, Chen X. Cetuximab conjugated and doxorubicin loaded silica nanoparticles for tumor-targeting and tumor microenvironment responsive binary drug delivery of liver cancer therapy. Materials Science and Engineering: C 2017;76:944-50. [DOI: 10.1016/j.msec.2017.03.131] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
15 Petruccelli E, Li Q, Rao Y, Kitamoto T. The Unique Dopamine/Ecdysteroid Receptor Modulates Ethanol-Induced Sedation in Drosophila. J Neurosci 2016;36:4647-57. [PMID: 27098705 DOI: 10.1523/JNEUROSCI.3774-15.2016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
16 Liu L, Liao JZ, He XX, Li PY. The role of autophagy in hepatocellular carcinoma: friend or foe. Oncotarget. 2017;8:57707-57722. [PMID: 28915706 DOI: 10.18632/oncotarget.17202] [Cited by in Crossref: 63] [Cited by in F6Publishing: 73] [Article Influence: 12.6] [Reference Citation Analysis]
17 Yang YA, Tang WJ, Zhang X, Yuan JW, Liu XH, Zhu HL. Synthesis, molecular docking and biological evaluation of glycyrrhizin analogs as anticancer agents targeting EGFR. Molecules 2014;19:6368-81. [PMID: 24853453 DOI: 10.3390/molecules19056368] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
18 Kim KH, Kim JY, Yoo JS. Mass spectrometry analysis of glycoprotein biomarkers in human blood of hepatocellular carcinoma. Expert Review of Proteomics 2019;16:553-68. [DOI: 10.1080/14789450.2019.1626235] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zhu M, Wang DD, Yan H. Genotype-determined EGFR-RTK heterodimerization and its effects on drug resistance in lung Cancer treatment revealed by molecular dynamics simulations. BMC Mol Cell Biol 2021;22:34. [PMID: 34112110 DOI: 10.1186/s12860-021-00358-6] [Reference Citation Analysis]
20 Hopkins MM, Liu Z, Meier KE. Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells. J Pharmacol Exp Ther 2016;359:124-33. [PMID: 27474750 DOI: 10.1124/jpet.116.233379] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
21 Berasain C, Avila MA. Amphiregulin. Semin Cell Dev Biol 2014;28:31-41. [PMID: 24463227 DOI: 10.1016/j.semcdb.2014.01.005] [Cited by in Crossref: 129] [Cited by in F6Publishing: 123] [Article Influence: 16.1] [Reference Citation Analysis]
22 Zhang Y, Wang S, Liu Z, Yang L, Liu J, Xiu M. Increased Six1 expression in macrophages promotes hepatocellular carcinoma growth and invasion by regulating MMP-9. J Cell Mol Med 2019;23:4523-33. [PMID: 31044528 DOI: 10.1111/jcmm.14342] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
23 Li W, Yu J, Lian B, Sun H, Li J, Zhang M, Li L, Li Y, Liu Q, Xie L. Identifying prognostic features by bottom-up approach and correlating to drug repositioning. PLoS One 2015;10:e0118672. [PMID: 25738841 DOI: 10.1371/journal.pone.0118672] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
24 Latasa MU, Salis F, Urtasun R, Garcia-Irigoyen O, Elizalde M, Uriarte I, Santamaria M, Feo F, Pascale RM, Prieto J, Berasain C, Avila MA. Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system. PLoS One 2012;7:e52711. [PMID: 23285165 DOI: 10.1371/journal.pone.0052711] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
25 Ranganathan S, Lopez-Terrada D, Alaggio R. Hepatoblastoma and Pediatric Hepatocellular Carcinoma: An Update. Pediatr Dev Pathol 2020;23:79-95. [PMID: 31554479 DOI: 10.1177/1093526619875228] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
26 Cui J, Shen HM, Lim LHK. The Role of Autophagy in Liver Cancer: Crosstalk in Signaling Pathways and Potential Therapeutic Targets. Pharmaceuticals (Basel) 2020;13:E432. [PMID: 33260729 DOI: 10.3390/ph13120432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
27 Wang DD, Ma L, Wong MP, Lee VH, Yan H. Contribution of EGFR and ErbB-3 Heterodimerization to the EGFR Mutation-Induced Gefitinib- and Erlotinib-Resistance in Non-Small-Cell Lung Carcinoma Treatments. PLoS One 2015;10:e0128360. [PMID: 25993617 DOI: 10.1371/journal.pone.0128360] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
28 Meng L, Ren Q, Meng Q, Zheng Y, He M, Sun S, Ding Z, Li B, Wang H. Trastuzumab modified silica nanoparticles loaded with doxorubicin for targeted and synergic therapy of breast cancer. Artificial Cells, Nanomedicine, and Biotechnology 2018;46:S556-63. [DOI: 10.1080/21691401.2018.1501380] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
29 Zhou X, Zheng R, Zhang H, He T. Pathway crosstalk analysis of microarray gene expression profile in human hepatocellular carcinoma. Pathol Oncol Res 2015;21:563-9. [PMID: 25480734 DOI: 10.1007/s12253-014-9855-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
30 Jacobi N, Seeboeck R, Hofmann E, Eger A. ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology. Cancers (Basel) 2017;9:E33. [PMID: 28417948 DOI: 10.3390/cancers9040033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
31 Berasain C, Nicou A, Garcia-Irigoyen O, Latasa MU, Urtasun R, Elizalde M, Salis F, Perugorría MJ, Prieto J, Recio JA. Epidermal growth factor receptor signaling in hepatocellular carcinoma: inflammatory activation and a new intracellular regulatory mechanism. Dig Dis. 2012;30:524-531. [PMID: 23108309 DOI: 10.1159/000341705] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
32 Ringelhan M, O'Connor T, Protzer U, Heikenwalder M. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. J Pathol. 2015;235:355-367. [PMID: 25196558 DOI: 10.1002/path.4434] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 11.1] [Reference Citation Analysis]
33 Mathew S, Ali A, Abdel-hafiz H, Fatima K, Suhail M, Archunan G, Begum N, Jahangir S, Ilyas M, Chaudhary AG, Al Qahtani M, Mohamad Bazarah S, Qadri I. Biomarkers for virus-induced hepatocellular carcinoma (HCC). Infection, Genetics and Evolution 2014;26:327-39. [DOI: 10.1016/j.meegid.2014.06.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
34 Olatunde A, Nigam M, Singh RK, Panwar AS, Lasisi A, Alhumaydhi FA, Jyoti Kumar V, Mishra AP, Sharifi-Rad J. Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs. Cancer Cell Int 2021;21:499. [PMID: 34535145 DOI: 10.1186/s12935-021-02202-5] [Reference Citation Analysis]
35 Zhou Q, Li Z, Zhou J, Joshi BP, Li G, Duan X, Kuick R, Owens SR, Wang TD. In vivo photoacoustic tomography of EGFR overexpressed in hepatocellular carcinoma mouse xenograft. Photoacoustics 2016;4:43-54. [PMID: 27766208 DOI: 10.1016/j.pacs.2016.04.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
36 Omran OM. EGFR and CXCR1 expression in thyroid carcinoma in Qassim Region-Saudi Arabia: Correlation with clinicopathological parameters. Pathophysiology 2019;26:145-51. [PMID: 31031057 DOI: 10.1016/j.pathophys.2019.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Balijepalli P, Sitton CC, Meier KE. Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special? Cells 2021;10:2059. [PMID: 34440828 DOI: 10.3390/cells10082059] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Lee AQ, Li Y, Gong Z. Inducible Liver Cancer Models in Transgenic Zebrafish to Investigate Cancer Biology. Cancers (Basel) 2021;13:5148. [PMID: 34680297 DOI: 10.3390/cancers13205148] [Reference Citation Analysis]
39 Ding Y, Zhang H, Lu A, Zhou Z, Zhong M, Shen D, Wang X, Zhu Z. Effect of urokinase-type plasminogen activator system in gastric cancer with peritoneal metastasis. Oncol Lett 2016;11:4208-16. [PMID: 27313768 DOI: 10.3892/ol.2016.4498] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]